Our neurological research frequently appears in leading academic journals and reflects a broad scope of interests.
Ozel O, Vaughn CB, Eckert SP, Jakimovski D, Lizarraga AA, Weinstock-Guttman B. Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives.. Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives. Patient Relat Outcome Measures. 2019; 10
Primma Eckert S, Weinstock-Guttman B. Diagnosis and Disease Monitoring: Advances in Clinical MRI for Multiple Sclerosis. Neurodiem.com. 2019
Smith Z, Bertolino N, Pol S, Preda M, Sveinsson M, Zivadinov R, Schweser F. Preclinical detection of leptomeningeal inflammation in the myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS). Proc Intl Soc Mag Reson Med. 2019; 27